Christianson Mark 4

What Happened

Mark Christianson, Director of Business Development at NeuroOne Medical Technologies Corp (NMTC), reported two open-market sales. On 2026-03-12 he sold 817 shares at $0.80 each (reported value $654), and on 2026-03-13 he sold 100 shares at $0.80 each ($80), for a combined 917 shares and roughly $734 total proceeds. These were sales (S), which are often routine dispositions and not necessarily a signal about company prospects.

Key Details

• Transaction dates & prices: 2026-03-12 — 817 shares @ $0.80 (≈ $653.60, reported $654); 2026-03-13 — 100 shares @ $0.80 ($80).
• Total sold: 917 shares for about $733.60 (rounded in filing to $734).
• Transaction code: S = Sale (open market/private sale).
• Shares owned after transaction: Not disclosed in this Form 4 filing.
• Filing: Form 4 filed electronically on 2026-03-16 covering the Mar 12–13 trades; the filing does not indicate a late filing or an explanatory footnote (no 10b5-1, tax withholding, or similar notes shown).

Context

Sales by officers or directors can be routine (diversification, personal liquidity, pre-set plans) and are usually less informative than purchases. The dollar value here is small (~$734), so this trade is minor in size relative to typical insider transactions and the company's market capitalization.